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Abstract Background:The prevalence of chronic obstructive pulmonary disease (COPD) according to guidelines of
today seems considerably higher than has been reported also in recent literature. Aim:To estimate the prevalence of
COPD as defined by BritishThoracic Society (BTS) criteria and the recent global initiative for chronic obstructive lung
disease (GOLD) criteria.Further aimswere to assess the proportionof underdiagnosis andof symptomsin subjectswith
COPD, andto studyrisk factors for COPD.Methods: In1996,5892 oftheObstructive LungDisease inNorthern Sweden
(OLIN) Study’s first cohort could be traced to a third follow-up survey, and 5189 completed responses (88%) were re-
ceived corresponding to 79% of the original cohort from December1985.Of the responders, a random sample of1500
subjectswere invitedto a structuredinterviewand a lung functiontest, and1237 ofthe invited completed a lung function
testwith acceptable quality.Results:In ages445 years, theprevalence of COPDaccording tothe BTS guidelineswas 8%,
while itwas14% according totheGOLDcriteria.The absolutelydominatingrisk factorswereincreasingage and smoking,
and approximately a half of elderly smokers fulfilled the criteria for COPD according to both the BTS and the GOLD
criteria. Family history of obstructive airway disease was also a risk factor, while gender was not.Of those fulfilling the
BTS criteria for COPD,94% were symptomatics, 69% had chronic productive cough, butonly 31% hadprior to the study
beendiagnosedashavingeitherchronicbronchitis, emphysema, orCOPD.Thecorresponding figures forCOPDaccord-
ing GOLDwere 88,51, and18%.Conclusions: In ages445 years, theprevalence of COPDaccording tothe BTS guidelines
was 8%, anditwas14% according tothe GOLDcriteria.Fiftypercentof elderly smokershaddeveloped COPD.Thelarge
majorityof subjects having COPDwere symptomatic, while the proportion ofthose diagnosed ashaving COPDor simi-
lardiagnoseswas small.r2002 Publishedby Elsevier Science Ltd.
Available online athttp://www.sciencedirect.com
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Chronic obstructive pulmonary disease (COPD) is a
common and costly disease with great implications for
health (1^5). It is further a growing cause of disability
and mortality (6). COPD was the sixth leading cause of
death in the world in1990 responsible for42 million or
4% of deaths (6). By 2020, the mortality is expected toReceived12 August 2002, accepted in revised form13 August 2002.
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Sweden.Fax: +46-8-303390; E-mail: bo.lundback@telia.comincrease to 4^5million, or 7% of all deaths, and COPD
is expected to rise to third position, after only ischemic
heart disease and cardiovascular disease (6).
Whereas numerous cross-sectional questionnaire stu-
dies of respiratory symptoms and diseases have been
reported during the last decades, results from studies
among elderly including lung function are still limited.
Comparisons of prevalence of COPD is distorted by the
use of di¡erent diagnostic criteria (7^12); further, the
prevalencevarydue to the age distribution of the studied
population samples. After ages of 40^50 years the pre-
valence of COPD increases considerably particularly
among smokers (7^9,11,12). Thus, evaluation of estimates
116 RESPIRATORYMEDICINEof the prevalence of COPD needs inclusion of elderly and
demand knowledge of age distribution and smoking ha-
bits in the examined populations.The slowly progressive
nature of COPD (3) means that the disease usually re-
mainsundetected for years, a reasonwhyunderdiagnosis
is large (13,14).
The Obstructive Lung Disease in Northern Sweden
Studies (OLIN) started as a prevalence study in 1986
(15).The third surveyof the ¢rst cohort of theOLIN-stu-
dies was performed in1996. An important aimwith the
survey was to measure the prevalence of COPD as de-
¢ned by BritishThoracic Society (BTS) criteria (3) that
conforms well with the apprehension of lung physicians
in the Nordic countries (8,9), as well as with the
recent Global Initiative for Chronic Obstructive Lung
Disease (GOLD) criteria (4).Further aimswere to assess
the degree of underdiagnosis, which re£ect the aware-
ness of COPD in society, and to study risk factors for
COPD.
MATERIALANDMETHODS
Study population
As part of the OLIN Studies, a random sample of 1500
subjects living in the northernmost province of Sweden
were invited to a structured interview and a lung func-
tion test in 1996 and 1997, and 1237 of the invited com-
pleted a lung function test with acceptable technique
(Table1).
The sample of 1500 invited was drawn from the re-
sponders of the postal questionnaire to the third survey
(16,17) of the OLIN Studies’ ¢rst cohort (15). In 1996, the
population of the cohort comprised 5933 subjects, of
whom 5892 could be traced to the third survey, and
5189 completed responses (88%) were received corre-
sponding to 79% of the original study cohort from De-
cember 1985. The subjects and their addresses were
provided by the provincial authorities from the Swedish
PopulationRegister.To the ¢rst survey in1985/86, all 6610
subjects born in 1919^20, 1934^35, and 1949^50 living inTABLE 1. Invited to and participants at structured interview an
women (W)
46^47 years
Studypopulation M F
Invited in1996^97 323 345
Participants1996^97 at interview,
in (%) of the invited
282
(87)
303
(88)
Ofwhomwith acceptable lung function
test in (%) ofthe invited
274
(85)
296
(86)eight representative areas of the province had been in-
vited (15).The participation rate in all three surveys has
been485% (15^18).
Methods
The methods included a lung function test and a struc-
tured interview.The study was approved by the ethical
committee at the University Hospital of Northern Swe-
den in Ume5.
Structured interview
The interview questionnaire (19) consisted of questions
about respiratory symptoms, use of asthma and other
airwaymedicines, past and present smoking habits, past
and present exposure to environmental tobacco smoke,
occupation, socio-economic group, and family history of
obstructive airway diseases. Among the respiratory
symptoms, quanti¢ed questions about cough, sputum
production, wheezing, dyspnea, attacks of shortness of
breath, chest tightness, respiratory symptoms in de¢ned
situations or exposures were included.To assure the va-
lidity of the data, similar questions about symptoms and
exposure had been asked for in the proceeding postal
questionnaire. The postal questionnaire, the same in all
surveys, was developed in1985 for the ¢rst OLIN survey
from a revised version (20) of the British Medical Re-
search Council questionnaire (21). It has later been used
in several Swedish (9,22^24) and Northern European
studies (25^27).
Lung function test
The lung function tests were performed by using a dry
spirometer (Mijnhardt Vicatest 5,The Netherlands).The
tests were performed following the ATS guidelines (28).
Swedish referencevalues reportedby Berglund etal. (29)
were used, which conforms well with the symptom-free
population of the OLIN-studies (19). The structured in-d lung function test in 1996^97 by age and sex; men (M) and
61^62 years 76^77 years All Total
M F M F M F
243 260 153 176 719 781 1500
220
(91)
235
(90)
116
(76)
126
(72)
618
(86)
664
(85)
1282
(85)
218
(90)
226
(87)
113
(74)
110
(63)
605
(84)
632
(81)
1237
(82)
REPORTFROM THEOBSTRUCTIVELUNGDISEASE 117terviews and the lung function tests were performed by
specially trained nurses. A reversibility test by using
4 0.2mg Ventoline Discuss was performed in all sub-
jects having either a ratio of FEV1/FVC or VCo0.7, or
FEV1o90% of predicted.
De¢nitions
COPDwas classi¢ed according to the criteria developed
by the BritishThoracic Society, BTS (3), and the Global
Initiative of COPD,GOLD (4).The GOLD criteria de¢ne
COPD as FEV1/FVCo0.7, and the BTS criteria include
both FEV1/FVCo0.7 and FEV1o80% of predicted values.
TheGOLD criteria include lung functionvalues after a
reversibility test, while the BTS criteria are not clear on
that point. Further, the BTS criterion mentions bothVC
and FVC as denominators for theratio.Wehaveused the
values after reversibility test, and the highest value of
either VC or FVC.
Other main di¡erences between the criteria include
the statement in GOLD that the lung function in COPD
is not fully reversible, while BTS states that the lung func-
tion in COPD is irreversible or only partly reversible.BTS
states that asthma with chronic obstruction may be in-
cluded in COPD, and the GOLD criteria do not clearly
recommend to distinguish between asthmawith chronic
obstruction and COPD.Thus, subjects with chronic ob-
struction, who stated they had asthma, have been in-
cluded in the analyses.
Analyses
Statistical analyses were performedby using the statisti-
cal package for the social sciences (SPSS).Chi-square test
and analysis of variance (ANOVA)wereused for uni- and
bi-variate calculations. Determinants for COPD were
calculated bymultiple logistic regression analysis.The in-
dependent variables used in themodelwere age, gender,
smoking habits, socio-economic group based on occupa-
tion (30), and family history of obstructive airway dis-
ease, i.e. of asthma, chronic bronchitis, emphysema or
COPD. Subjects who currently smoked every week or
had stopped smokingwithin12monthsprior to the study
were classi¢ed as smokers,while thosewhohad stopped
smokingmore than12 months previously were classi¢ed
as ex-smokers. Aretrospective assumption ofpack-years
wasmade; however, these data havenotbeenused in the
current presentation due to lack of validity.
RESULTS
Participation
Totally1282 subjects, 86%ofmen and 85% of women, out
of the 1500 invited participated at the structured inter-
views.Of the lung function tests, 1237 were included inthe analyses, as 32 women and13 men did not complete
lung function tests satisfactorily. More than 85% of the
invited amongbothmen andwomen in the twoyoungest
age groups completed acceptable lung function tests,
while the corresponding ¢gures in the oldest age group
was amongmen 74% and among women 63% (Table1).
Smoking habits
Of women, 25.6% were current smokers vs. 23.6% of
men. Almost a half, 47.0%, of men were ex-smokers
vs.23.7% of women, while 50.6% of women were non-
smokers vs. 29.3% of men. Smokers were most common
among the youngest age group in both men and women
(Table 2).
Prevalence of COPD
The prevalence of COPD was strongly smoking depen-
dent and increased considerably with increasing age
(Table 3).The prevalence among non-smokers according
to the BTS guidelinewas1% among the subjects aged 46^
47 years, 2% among those aged 61^62 years, while it was
16% in the age group of 76^77 years.The corresponding
¢gures among non-smokers according to the GOLD
guidelines were 3, 5, and 21%, respectively. Among smo-
kers, the prevalence of COPD according to BTSwas 5%
in those aged 46^47 years, 24% in the age group 61^62
years, and 45% among the oldest.The corresponding ¢g-
ures among smokers according to the GOLD guidelines
were11, 42, and 50%, respectively.Theprevalence among
ex-smokers was generally in between non-smokers and
smokers, except among women in the oldest group, in
which COPD was similar in ex-smokers and smokers.
No signi¢cant gender di¡erences were found in preva-
lence of COPD either according to BTS or the GOLD
guidelines (Table 3). Also, prevalence rates of subjects
having FEV1o80% of predictedvalues are given (Table 3).
Respiratory symptoms in subjectswith
COPD
Of all subjects ful¢lling the criteria for COPD according
to the BTS guidelines, 69% had chronic productive cough,
and 94% had either long-standing cough, sputumproduc-
tion, recurrent wheeze, attacks of shortness of breath,
or dyspnea of at least grade 2. Further, prior to the sur-
veyonly 31%were diagnosed ashaving chronicbronchitis,
emphysema, orCOPD, and if use of asthmamedicines or,
by the subject, preferred diagnosis of asthma were
added, 60% were at least in part detected by the health-
care system. When de¢ning COPD according to the
GOLD criteria, a lower proportion was symptomatic,
88, 51% reported chronic productive cough, while 39%
used asthma medicines or were diagnosed as having any
TABLE 2. Smokinghabits by age and sex; men (M) andwomen (W)
46^47 years 61^62 years 76^77 years All Total
Smokinghabits M F M F M F M F
Non-smokers 32.5 38.5 28.9 54.4 22.1 75.8 29.3 50.6 40.2
Ex-smokers 39.2 27.0 46.3 22.6 67.3 16.6 47.0 23.7 35.0
Smokers, all 28.2 34.5 24.8 23.0 10.6 7.5 23.6 25.6 24.7
o5 cig/day 5.1 3.4 3.2 3.1 1.8 2.3 3.8 3.1 3.5
5^14 cig/day 7.3 20.9 7.3 15.5 5.3 4.4 6.9 16.1 11.6
X15 cig/day 13.5 9.5 10.1 4.4 0.9 0 9.9 6.0 7.9
Missing 2.3 0.7 4.1 0 2.7 0.9 3.1 0.5 1.8
TABLE 3. Prevalence of COPDaccording tothe BTSandGOLDcriteria, respectively, andof FEV1o80% ofpredictedvaluesby
age and sex.Di¡erence (P-value) by sex, age and smokinghabits
Prevalence Category 46^47 y 61^62 y 76^77 years All All Di¡erence (P-value) by
Men Women Men Women Men Women Men Women Sex Age Smoking
FEV1o80% Non-smokers 3.4 7.0 3.2 17.1 32.0 16.9 7.3 13.4 11.3
Ex-smokers 4.7 2.5 12.9 15.7 22.4 44.4 12.3 12.1 12.2
Smokers 9.1 13.7 24.1 44.2 58.3 25.0 18.9 24.1 21.6
Total 5.5 8.1 12.8 23.0 28.3 21.8 12.4 15.8 14.1 0.084 o0.001 o0.001
GOLD Non-smokers 3.4 2.6 6.3 4.9 28.0 19.3 7.9 7.8 7.8
Ex-smokers 3.7 8.8 15.8 9.8 27.6 55.6 14.4 14.8 14.5
Smokers 13.0 9.8 38.9 46.2 66.7 25.0 27.3 22.2 24.6
Total 6.2 6.8 18.8 15.5 31.9 25.5 15.5 13.1 14.3 0.228 o0.001 o0.001
BTS Non-smokers 0 2.6 0 3.3 20.0 14.5 2.8 5.9 3.8
Ex-smokers 1.9 2.5 7.9 5.9 17.1 27.8 8.1 6.7 7.6
Smokers 3.9 5.9 16.7 30.8 58.3 25.0 13.3 14.8 14.1
Total 1.8 3.7 7.8 10.2 22.1 17.3 7.8 8.4 8.1 0.691 o0.001 o0.001
118 RESPIRATORYMEDICINEobstructive airway disease. Only 18% had prior to the
studybeen diagnosed as having either chronic bronchitis,
emphysema, or COPD (Table 4).
Multivariate relationships
When including age, gender, smoking habits, family his-
tory of obstructive airway disease, and socio-economic
group in the model, age and smoking appeared as the
two major risk factors.COPD according to the BTS cri-
teria as the dependent variable yielded an odds ratio
(OR) of 4.96 for the age 61^62 years, and 18.3 for the
age 76^77 years vs. age 46^47 years.OR for the smoking
category 5^14 cigarettes per day was 8.00.To have a fa-
milyhistoryof obstructive airwaydiseasewas associated
with a risk for COPD according to the BTS guidelines of
2.16 (Table 5).
When performing the analyses by using the GOLD
criteria for COPD as the dependent variable, a similarpattern was found. However, the OR for the individual
riskswere considerably lower thanwhen the BTS criter-
ia were used as the dependent variable. Risks for having
FEV1o80% of predicted values were also calculated, and
the OR were even more lower than had been found
when using the GOLD criteria for COPD (Table 5).
Socio-economic group as an independent risk factor
was also analyzed in themultivariatemodel.The only sig-
ni¢cant associationwas thatmanualworkershad a signif-
icantly higher risk of having COPD, OR 2.07. However,
this was found only when COPD was de¢ned according
to the GOLD criteria (Table 5).
DISCUSSION
The study suggests that approximately 50% of smokers
maydevelopCOPD, not15^20 % that has beenproposed
in the literature since decades (31) and recently as well
TABLE 4. Proportion (%) ofdiagnosed subjects, symptomatics, andusers of asthmamedicines or Expectorantia, includingN-
acetylcysteine, among subjects with COPD according to GOLD- and BTS guidelines, respectively, and among subjects with
FEV1o80 % of predictedvalue
Condition FEV1o80 % of predicted COPD^GOLD COPD^BTS
Symptomatics 89 88 94
Chronic productive cough 54 51 69
Physician-diagnosedchronic bronchitis, emphysema, or COPD 22 18 31
Use ofmedicines 33 26 42
Use ofmedicines or any self-reported OAD 48 39 60
REPORTFROM THEOBSTRUCTIVELUNGDISEASE 119(2,32). Thus, the prevalence of COPD according to the
guidelines of today, particularly among smokers, seems
considerably higher than has been reported. Further,
the study exempli¢es the obvious dependency of the
used criteria when measuring prevalence of COPD. In
ages 445 years, the prevalence of COPD according to
the BTS guidelines (3) was 8%,while itwas14% according
to the GOLD criteria (4), similar in men and women ac-
cording to both criteria.The high participation rate sup-
ports the validity of the results.
Several international (1^4) and national guidelines
(33,34) have de¢ned diagnostic criteria for COPD, how-
ever, most often di¡erently. The BTS (3) and the GOLD
(4) haverecommended a cuto¡ pointof the FEV1/FVC (or
VC) ratio of less than 0.7, while European Respiratory
Society (ERS) recommend an FEV1/VC ratio ofo88% of
predicted in men ando89% of predicted in women (1).
From a physiological point of view, the ATS criteria (2)
are not as distinct as the BTS, ERS, and GOLD criteria,
and allow an interpretation of the investigator, and ATS
states in their most recent guidelines COPD to be em-
physema and the obstructive form of chronic bronchitis.
In opposite to the GOLD criteria, the BTS criteria do
not include in COPD subjects having an FEV1X80% of
predicted values. This has support in the clinical appre-
hension of physicians also in the Nordic countries, and
has been used more or less similarly in Nordic reports
of COPD or its synonyms (7^9).Neither BTS norGOLD
criteria demand a detailed di¡erentiation between asth-
ma and COPD in cases with chronic obstruction. A dis-
advantage is theuse of a ¢xedratio,whichmaycausebias
by including too few cases among young adults and too
many among elderly.
The prevalence according to GOLD was almost twice
ashigh compared to theBTS criteria.The large di¡erence
between the two guidelines in prevalence occurred par-
ticularly in the ages 46^47 and 61^62 years, and not
among the elderly. Among elderly, once the FEV1 was
o80% of predicted, the FEV1/FVC ratio was alsoo0.7,
and on the other hand, among those having FEV1/
FVCo0.7, the greatmajority also had FEV1o80% of pre-
dicted.Further,GOLD point out also persons at risk, i.e.
symptomatic persons comprising a large proportion ofadult populations, as found previously in our studies (15)
and in studies in other countries as well (35,36).
Measures of prevalence of COPD have been based on
a large number of di¡erent diagnostic and lung function
criteria. Also, an Italian study illustrates that data on
prevalence of COPD have to be interpreted with cau-
tion. The study of general population in northern Italy
showed very large di¡erences in prevalence estimates of
COPD when using the 1987 AmericanThoracic Society
criteria, the1995 European Respiratory Society criteria,
or ‘‘clinical criteria’’ (37).
Several Nordic community surveys allow estimations
of prevalence and indicate that 4^6% of the adult popu-
lation have COPD (7^9,24). As found in our study, the
prevalence increases rapidly with increasing age particu-
larly among smokers, and surveys from the last decades
show only small di¡erences in prevalence between men
and women (8,9). A survey of a general population sam-
ple aged18^73 years in the Bergen area, Norway, found
that 6% had FEV1/FVCo0.7, 12% had FEV1o80% of pre-
dicted, and 4.5% had both these criteria (8), which con-
forms to the BTS criteria for COPD.The prevalencewas
similar to ours in comparable ages (445 years). Also, the
referred study in Italy resulted in a prevalence similar to
studies in the Nordic countries (37).
Theprevalence ofCOPDwas estimatedat10.6%when
de¢ned according to the ERS criteria (FEV1/FVC ratio
o88% predicted in men and o89% in women (1)) in a
study of random population samples aged 40^69 years
in seven areas of Spain (11). A similar prevalence, 10%
among men and 11% in women, but in the ages 16^65
years, was found in a study in the U.K. (38). The mea-
sured condition was de¢ned as FEV1r2 SD of predicted
values (38). A comparison of community surveys in Italy,
Sweden, and Norway yielded slightly higher prevalence
estimates for bronchitic symptoms and air£ow limitation
in Sweden and Norway (39).
Our ¢nding that around 50% of elderly smokers have
developed COPD has support in some other studies in-
cluding the study in Spain (11), a Finnish study (10), and
also in the U.S.Nhanes III study (12). In the U.S. survey of
16 695 subjects aged17^69 years performedduring1988^
94, air£ow limitationwas de¢nedclose to the BTS criter-
TABLE 5. Risk factors (oddsratios and 95% con¢denceintervals,CI) for COPDaccording toGOLDand BTS criteria, and for FEV1o80% predictedvaluesbymultiple logistic regression
analysis.The independent variables include age, sex, familyhistoryof obstructive airwaydisease, smokinghabits and socio-economic group
Independent variables Dependent variables
FEV1o80% pred COPD^GOLD COPD^BTS
Variables Categories OR 95% CI OR 95% CI OR 95% CI
Age 46^47 y 1 1 1
61^62 y 3.86 2.45^6.08 3.78 2.34^6.09 4.96 2.51^9.81
76^77 y 6.75 3.79^12.0 11.4 5.88^17.7 18.3 8.08^41.5
Sex Men 1 1 1
Women 1.45 0.91^2.29 1.36 0.84^2.19 1.40 0.76^2.57
Familyhistoryof obstructive No 1 1 1
airwaydisease Yes 1.48 1.00^2.19 1.36 0.90^2.06 2.16 1.31^3.56
Smokinghabits Non-smokers 1 1 1
Ex-smokers 1.41 0.89^2.24 2.14 1.31^3.50 1.98 1.04^3.79
Smokerso5 cig/day 1.35 0.44^4.20 4.39 1.66^11.6 1.78 0.36^8.73
5^14 cig/day 4.06 2.36^6.98 6.44 3.37^11.6 8.00 3.84^16.7
X15 cig/day 4.73 2.42^9.24 8.04 3.99^16.2 8.77 3.58^21.5
Socio-economic group Manualworkers 1 1 1
Manualworkers in industry 1.15 0.61^2.16 2.07 1.10^3.89 1.23 0.50^3.02
Manualworkers in service 1.38 0.77^2.46 1.13 0.60^2.13 1.38 0.60^3.13
Assistant non-manual 1.11 0.59^2.09 1.09 0.55^2.15 1.59 0.67^3.78
Housewives 0.48 0.14^1.60 0.63 0.19^2.03 0.40 0.07^2.18
Self-employed 0.86 0.29^2.49 1.16 0.42^3.27 1.53 0.43^5.47
Others andunknown 1.03 0.48^2.22 0.95 0.43^2.09 1.08 0.40^2.91
120
RESPIR
ATO
RY
M
ED
ICIN
E
REPORTFROM THEOBSTRUCTIVELUNGDISEASE 121ia for COPD (3) as in ours and in the Norwegian survey
(8). The prevalence of impaired lung function was 5.2%,
and the prevalence of a diagnosis of obstructive airway
diseasewas slightly higher (12).
Increasing age and smoking appeared as the two dom-
inating risk factors for COPD. Already moderate smok-
ing yielded an OR of 8 compared to non-smokers in this
middle-aged and elderly sample. All other risk factors
were close to or belowORof two.Female gender was a
trend in the multivariate analyses, but not signi¢cant,
while the overallprevalence inmen andwomenwas simi-
lar. However, in female smokers aged 61^62 years, the
prevalence of COPD was greater than in the male smo-
kers of same age. Several studies have shown women to
be more susceptible to tobacco smoke than men, and a
greater additional e¡ectof smokingon the annual decline
in lung functionwas obtained inwomen (40,41).
As found by others, family history of obstructive air-
way disease was signi¢cantly associated with COPD
(25,27). Among socio-economic groups, only manual
workers in industry reached signi¢cance, as found for
chronic bronchitis in other studies (25), andno other sig-
ni¢cant relations were found.Occupational airborne ex-
posure is a known risk factor for COPD (42).Generally,
by using themore speci¢c BTS criteria for COPD as the
dependent variable in the multivariate models, greater
risks were yielded than by using the GOLD criteria.
A greatmajority of the subjectswith COPDreported
chronic respiratory symptoms.Despite the fact that the
majority was symptomatic, above or just below 90% ac-
cording to the BTS or the GOLD criteria, respectively,
only aminorityof themwere diagnosed as having COPD.
Of those ful¢lling the BTS criteria, less than one-third
had prior to the study been diagnosed as having either
chronic bronchitis, emphysema, or COPD. The corre-
sponding proportion for COPD de¢nedby following the
GOLD criteria was less than 20%. No improvement of
theunderdiagnosis has takenplace, when comparedwith
data from1986 to 87 and1993 to 94 (14).
The new guidelines may promote use of spirometry
and early detection of COPD. The results support the
view that smokers with respiratory symptoms should
undergo measure of lung function. The identi¢cation of
early cases of COPD supports early onset of smoking
cessation, the only action of importance in preventing a
severe outcome of the disease.However, the clinical re-
levance of having a normal FEV1 but a pathologic ratio,
i.e. mild COPD according to the GOLD criteria, is so
far unknown. Prospective studies are needed to deter-
mine its importance and long-term outcome.
In conclusion, the prevalence of COPD, particularly
among smokers, according to the guidelines of today
seems considerably higher than that generally reported
in current literature, and around 50% of smokers devel-
oped COPD.The study illustrates the large dependency
of the criteria of disease, the age composition and thesmoking habits of the study population when measuring
the prevalence of COPD.
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